Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Tyrosine-protein kinase JAK1 (Protein)

Uniprotkb:P23458

Id:ccab9977-a130-5bb0-a65b-09fbc38a6811

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Tyrosine-protein kinase JAK1 's neighborhood in the knowledge graph.

Results found

Linked to

	Label	Description
	US8962608, 17-88 bioactivity Tyrosine-protein kinase JAK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US8895544, 21 bioactivity Tyrosine-protein kinase JAK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US9346810, 155 bioactivity Tyrosine-protein kinase JAK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US9328099, 34-22 bioactivity Tyrosine-protein kinase JAK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US8637526, 299 bioactivity Tyrosine-protein kinase JAK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US8962608, 17-32 bioactivity Tyrosine-protein kinase JAK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US9216999, 28 bioactivity Tyrosine-protein kinase JAK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US8962608, 25-28 bioactivity Tyrosine-protein kinase JAK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	US9328099, 3-40 bioactivity Tyrosine-protein kinase JAK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	N-(4-(5-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-ylamino)phenyl)acetamide bioactivity Tyrosine-protein kinase JAK1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US8962608, 17-88 bioactivity Tyrosine-protein kinase JAK1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US8895544, 21 bioactivity Tyrosine-protein kinase JAK1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US9346810, 155 bioactivity Tyrosine-protein kinase JAK1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US9328099, 34-22 bioactivity Tyrosine-protein kinase JAK1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US8637526, 299 bioactivity Tyrosine-protein kinase JAK1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US8962608, 17-32 bioactivity Tyrosine-protein kinase JAK1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US9216999, 28 bioactivity Tyrosine-protein kinase JAK1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US8962608, 25-28 bioactivity Tyrosine-protein kinase JAK1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

US9328099, 3-40 bioactivity Tyrosine-protein kinase JAK1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

N-(4-(5-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-ylamino)phenyl)acetamide bioactivity Tyrosine-protein kinase JAK1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.